[The care pathway of a child with leukaemia]

Anne-Claire Lebot1, Céline Pastorelli1, Emmanuelle Tessier1

  • 1Service d'onco-hématologie pédiatrique, Hôpital mère-enfant, 7 quai Moncousu, 44093 Nantes cedex, France.

Insights

Childhood leukaemia impacts 500 French families annually, centering their lives around the disease. A unique bond forms between the child, family, and pediatric hematology-oncology team throughout treatment and recovery.

Area of Science:

  • Pediatric Hematology-Oncology
  • Childhood Cancer Research

Background:

  • Childhood leukaemia affects approximately 500 children and their families in France each year.
  • The diagnosis profoundly impacts family life, shifting focus to the disease.
  • A unique patient-family-provider relationship develops during treatment.

Purpose of the Study:

  • To explore the evolving relationship between children with leukaemia, their families, and healthcare professionals.
  • To understand the psychosocial dynamics within pediatric hematology-oncology departments.

Main Methods:

  • Qualitative analysis of patient and family experiences.
  • Longitudinal observation within a pediatric hematology-oncology setting.
  • Interviews with healthcare staff.

Main Results:

  • The diagnosis of leukaemia creates a shared journey for children and families.
  • A distinct and evolving relationship is formed with the medical team.
  • This relationship is crucial from diagnosis through long-term follow-up.

Conclusions:

  • The journey of childhood leukaemia involves a significant psychosocial component.
  • Strong therapeutic relationships are vital for supporting children and families.
  • Further research into optimizing these relationships is warranted.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K